RxDoctor Payments Data

Fred Thomas Lee, MD

Plastic Surgery · Las Vegas, NVNPI 1457593238

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,440 of the $3,387 with a category attached, or 72.1%. 22 manufacturers reported payments, led by Goode Surgical Inc at 26.4% of the total. Reporting peaked in 2020 at $927 and has fallen 60.1% since, to $370 in 2025.

$3,387in general payments, 2019–2025

Across 78 payments — averaging $43.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Goode Surgical Inc$896
  • AbbVie$752
  • TELA Bio, Inc.$385
  • Mentor Worldwide LLC$279
  • Smith+Nephew$194
  • Galderma Laboratories, L.p.$174
  • plus $707 from 16 others

What the payments were for

  • Food & beverage$2,44072%
  • Education$94628%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,387 in reported general payments places this provider in the 65th percentile of 34 plastic surgery providers in Nevada.

See all plastic surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$15,773
Medicare patients
45
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl22$59
Tramadol Hcl14$26

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →